Assessing individual risk for high-risk colorectal adenoma at first-time screening colonoscopy
- PMID: 25820865
- PMCID: PMC4503471
- DOI: 10.1002/ijc.29533
Assessing individual risk for high-risk colorectal adenoma at first-time screening colonoscopy
Abstract
Assessing risk of colorectal adenoma at first-time colonoscopy that are of higher likelihood of developing advanced neoplasia during surveillance could help tailor first-line colorectal cancer screening. We developed prediction models for high-risk colorectal adenoma (at least one adenoma ≥1 cm, or with advanced histology, or ≥3 adenomas) among 4,881 asymptomatic white men and 17,970 women who underwent colonoscopy as their first-time screening for colorectal cancer in two prospective US studies using logistic regressions. C-statistics and Hosmer-Lemeshow tests were used to evaluate discrimination and calibration. Ten-fold cross-validation was used for internal validation. A total of 330 (6.7%) men and 678 (3.8%) women were diagnosed with high-risk adenoma at first-time screening colonoscopy. The model for men included age, family history of colorectal cancer, BMI, smoking, sitting watching TV/VCR, regular aspirin/NSAID use, physical activity, and a joint term of multivitamin and alcohol. For women, the model included age, family history of colorectal cancer, BMI, smoking, alcohol, beef/pork/lamb as main dish, regular aspirin/NSAID, calcium, and oral contraceptive use. The C-statistic of the model for men was 0.67 and 0.60 for women (0.64 and 0.57 in cross-validation). Both models calibrated well. The predicted risk of high-risk adenoma for men in the top decile was 15.4% vs. 1.8% for men in the bottom decile (Odds Ratio [OR] = 9.41), and 6.6% vs. 2.1% for women (OR = 3.48). In summary, we developed and internally validated an absolute risk assessment tool for high-risk colorectal adenoma among the US population that may provide guidance for first-time colorectal cancer screening.
Keywords: colonoscopy; colorectal adenoma; risk prediction; screening.
© 2015 UICC.
Figures
Similar articles
-
Risk of Advanced Neoplasia in First-Degree Relatives with Colorectal Cancer: A Large Multicenter Cross-Sectional Study.PLoS Med. 2016 May 3;13(5):e1002008. doi: 10.1371/journal.pmed.1002008. eCollection 2016 May. PLoS Med. 2016. PMID: 27138769 Free PMC article.
-
Development and validation of a clinical score for predicting risk of adenoma at screening colonoscopy.Cancer Epidemiol Biomarkers Prev. 2015 Jun;24(6):913-20. doi: 10.1158/1055-9965.EPI-14-1321. Epub 2015 Mar 23. Cancer Epidemiol Biomarkers Prev. 2015. PMID: 25800242 Free PMC article. Clinical Trial.
-
Colorectal cancer risk factors in the detection of advanced adenoma and colorectal cancer.Cancer Epidemiol. 2013 Jun;37(3):278-83. doi: 10.1016/j.canep.2013.02.004. Epub 2013 Mar 9. Cancer Epidemiol. 2013. PMID: 23491770
-
High-risk family colorectal cancer screening service in Ireland: Critical review of clinical outcomes.Cancer Epidemiol. 2017 Oct;50(Pt A):30-38. doi: 10.1016/j.canep.2017.07.002. Epub 2017 Aug 4. Cancer Epidemiol. 2017. PMID: 28783501 Review.
-
Gender as a risk factor for advanced neoplasia and colorectal cancer: a systematic review and meta-analysis.Clin Gastroenterol Hepatol. 2009 Jun;7(6):676-81.e1-3. doi: 10.1016/j.cgh.2009.01.008. Clin Gastroenterol Hepatol. 2009. PMID: 19514116 Review.
Cited by
-
Molecular Biologic and Epidemiologic Insights for Preventability of Colorectal Cancer.J Natl Cancer Inst. 2022 May 9;114(5):645-650. doi: 10.1093/jnci/djab229. J Natl Cancer Inst. 2022. PMID: 34978574 Free PMC article.
-
Immunohistochemical expression of heparanase isoforms and syndecan-1 proteins in colorectal adenomas.Eur J Histochem. 2016 Feb 17;60(1):2590. doi: 10.4081/ejh.2016.2590. Eur J Histochem. 2016. PMID: 26972718 Free PMC article.
-
Outcomes of screening and surveillance in people with two parents affected by colorectal cancers: experiences from the Familial Bowel Cancer Service.Hered Cancer Clin Pract. 2019 Aug 16;17:25. doi: 10.1186/s13053-019-0122-8. eCollection 2019. Hered Cancer Clin Pract. 2019. PMID: 31428211 Free PMC article.
-
Aspirin, ibuprofen, and reduced risk of advanced colorectal adenoma incidence and recurrence and colorectal cancer in the PLCO Cancer Screening Trial.Cancer. 2021 Sep 1;127(17):3145-3155. doi: 10.1002/cncr.33623. Epub 2021 May 11. Cancer. 2021. PMID: 33974712 Free PMC article.
-
Adherence to the World Cancer Research Fund/American Institute for Cancer Research cancer prevention recommendations throughout the life course and risk of colorectal cancer precursors.Br J Cancer. 2023 Jun;128(12):2243-2252. doi: 10.1038/s41416-023-02255-5. Epub 2023 Apr 7. Br J Cancer. 2023. PMID: 37029199 Free PMC article.
References
-
- Edwards BK, Ward E, Kohler BA, Eheman C, Zauber AG, Anderson RN, Jemal A, Schymura MJ, Lansdorp-Vogelaar I, Seeff LC, van Ballegooijen M, Goede SL, et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer. 2010;116:544–73. - PMC - PubMed
-
- Levin B, Lieberman DA, McFarland B, Andrews KS, Brooks D, Bond J, Dash C, Giardiello FM, Glick S, Johnson D, Johnson CD, Levin TR, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology. 2008;134:1570–95. - PubMed
-
- Regula J, Rupinski M, Kraszewska E, Polkowski M, Pachlewski J, Orlowska J, Nowacki MP, Butruk E. Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia. The New England journal of medicine. 2006;355:1863–72. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical